PROTECTIVE EFFECT OF AN SGLT2 INHIBITOR ON ER STRESS THROUGH REDUCTION OF ECTOPIC LIPID DEPOSITION IN RENAL TUBULES IN OBESE MICE

被引：0
|
作者：
Takata, Tomoaki [1 ]
Hosokawa, Kohshiro [1 ]
Sugihara, Takaaki [1 ]
Matono, Tomomitsu [1 ]
Koda, Masahiko [1 ]
Kanda, Tsutomu [1 ]
Ogawa, Masaya [1 ]
Ida, Ayami [1 ]
Mae, Yukari [1 ]
Yamamoto, Marie [1 ]
Iyama, Takuji [1 ]
Fukuda, Satoko [1 ]
Isomoto, Hajime [1 ]
机构：
[1] Tottori Univ, Fac Med, Div Med & Clin Sci, Yonago, Tottori, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0933
引用
收藏
页码：1260 / 1260
页数：1
相关论文
共 50 条
  • [1] Ectopic lipid deposition upregulates SGLT2 and GLUT1 in renal tubules
    Li, T.
    Wu, T.
    Sun, Z.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 215 - 215
  • [2] Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules
    Hosokawa, Kohshiro
    Takata, Tomoaki
    Sugihara, Takaaki
    Matono, Tomomitsu
    Koda, Masahiko
    Kanda, Tsutomu
    Taniguchi, Sosuke
    Ida, Ayami
    Mae, Yukari
    Yamamoto, Marie
    Iyama, Takuji
    Fukuda, Satoko
    Isomoto, Hajime
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [3] Luseogliflozin, a SGLT2 Inhibitor, Does Not Affect Glucose Uptake Kinetics in Renal Proximal Tubules of Live Mice
    Zhang, Anqi
    Nakano, Daisuke
    Kittikulsuth, Wararat
    Yamashita, Yuka
    Nishiyama, Akira
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [4] Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice
    Okauchi, Seizo
    Shimoda, Masashi
    Obata, Atsushi
    Kimura, Tomohiko
    Hirukawa, Hidenori
    Kohara, Kenji
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (03) : 772 - 782
  • [5] Protective Effects of SGLT2 Inhibitor Luseogliflozin on Pancreatic Beta Cells in Obese Type 2 Diabetic db/db Mice
    Okauchi, Seizou
    Simoda, Masashi
    Obata, Atsushi
    Kimura, Tomohiko
    Hirukawa, Hidenori
    Kohara, Kenji
    Kaneto, Hideaki
    Kaku, Kohei
    DIABETES, 2015, 64 : A586 - A586
  • [6] A SGLT2 INHIBITOR LUSEOGLIFLOZIN DOES NOT AFFECT GLUCOSE UPTAKE DYNAMICS IN PROXIMAL TUBULES OF LIVE MICE
    Zhang, Anqi
    Nakano, Daisuke
    Nishiyama, Akira
    NEPHROLOGY, 2021, 26 : 5 - 6
  • [7] Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy
    Abdel-Wahab, Ali F.
    Bamagous, Ghazi A.
    Al-Harizy, Randa M.
    ElSawy, Naser A.
    Shahzad, Naiyer
    Ibrahim, Ibrahim A.
    Al Ghamdi, Saeed S.
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 59 - 66
  • [8] SGLT2 INHIBITOR PREVENTS RENAL FIBROSIS AFTER RENAL ISCHEMIA/REPERFUSION INJURY IN MICE
    Nishiyama, Akira
    Xhang, Yifan
    Nakano, Daisuke
    JOURNAL OF HYPERTENSION, 2018, 36 : E22 - E22
  • [9] EFFECTS OF A SGLT2 INHIBITOR ON RENAL EXPRESSION OF SODIUM TRANSPORTERS IN OBESE METABOLIC SYNDROME RATS
    Rahman, Asadur
    Kittikulsuth, Wararat
    Hitomi, Hirofumi
    Nakano, Daisuke
    Nishiyama, Akira
    JOURNAL OF HYPERTENSION, 2016, 34 : E433 - E433
  • [10] The Effects of the SGLT2 Inhibitor Empagliflozin on Fatty Liver in Diet-Induced Obese Mice
    Wang, Wei
    Guo, Wanrong
    Jian, Ying
    Shen, Yunfeng
    Xu, Fen
    DIABETES, 2020, 69
12345